These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23896722)

  • 21. Risperidone versus typical antipsychotic medication for schizophrenia.
    Hunter RH; Joy CB; Kennedy E; Gilbody SM; Song F
    Cochrane Database Syst Rev; 2003; (2):CD000440. PubMed ID: 12804396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin.
    Chaudhry IB; Husain MO; Khoso AB; Kiran T; Husain MI; Qurashi I; Rahman RU; Mehmood N; Drake R; Husain N; Deakin B
    J Psychopharmacol; 2024 Sep; 38(9):818-826. PubMed ID: 39233601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT3R) in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis.
    Botrel TE; Clark OA; Clark L; Paladini L; Faleiros E; Pegoretti B
    Support Care Cancer; 2011 Jun; 19(6):823-32. PubMed ID: 20495832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach.
    Sauriol L; Laporta M; Edwardes MD; Deslandes M; Ricard N; Suissa S
    Clin Ther; 2001 Jun; 23(6):942-56. PubMed ID: 11440294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risperidone versus olanzapine for schizophrenia.
    Jayaram MB; Hosalli P; Stroup S
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005237. PubMed ID: 16625629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy, safety and effectiveness of ondansetron compared to other serotonin-3 receptor antagonists (5-HT3RAs) used to control chemotherapy-induced nausea and vomiting: systematic review and meta-analysis.
    Simino GP; Marra LP; Andrade EI; Acúrcio Fde A; Reis IA; De Araújo VE; Cherchiglia ML
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1183-94. PubMed ID: 27180992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New generation antipsychotics for first episode schizophrenia.
    Rummel C; Hamann J; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2003; (4):CD004410. PubMed ID: 14584012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials.
    Correll CU; Maayan L; Kane J; Hert MD; Cohen D
    J Clin Psychiatry; 2016 Jun; 77(6):e746-56. PubMed ID: 27337425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents.
    Glick ID; Lemmens P; Vester-Blokland E
    Int Clin Psychopharmacol; 2001 Sep; 16(5):265-74. PubMed ID: 11552769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of ondansetron in the treatment of schizophrenia.
    Bennett AC; Vila TM
    Ann Pharmacother; 2010; 44(7-8):1301-6. PubMed ID: 20516364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Add-on fluvoxamine treatment for schizophrenia: an updated meta-analysis of randomized controlled trials.
    Kishi T; Hirota T; Iwata N
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):633-41. PubMed ID: 23605347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ondansetron and simvastatin added to treatment as usual in patients with schizophrenia: study protocol for a randomized controlled trial.
    Chaudhry IB; Husain N; Husain MO; Hallak J; Drake R; Kazmi A; Rahman Ru; Hamirani MM; Kiran T; Mehmood N; Stirling J; Dunn G; Deakin B
    Trials; 2013 Apr; 14():101. PubMed ID: 23782463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
    Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
    Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials.
    Zheng W; Cai DB; Yang XH; Li L; Zhang QE; Ng CH; Ungvari GS; Li XB; Ning YP; Xiang YT
    J Psychiatr Res; 2018 Aug; 103():244-251. PubMed ID: 29906709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy of three 5-HT3 antagonists (granisetron, ondansetron, and tropisetron) plus dexamethasone for the prevention of cisplatin-induced acute emesis: a randomized crossover study.
    Chua DT; Sham JS; Kwong DL; Kwok CC; Yue A; Foo YC; Chan R
    Am J Clin Oncol; 2000 Apr; 23(2):185-91. PubMed ID: 10776982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.
    Harvey RC; James AC; Shields GE
    CNS Drugs; 2016 Jan; 30(1):27-39. PubMed ID: 26801655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2003; (1):CD001359. PubMed ID: 12535408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.